A top vaccine expert and FDA adviser has warned that there is insufficient evidence to recommend the new booster shot for healthy young adults and said it could carry risks.
Dr. Paul Offit, MD is an American pediatrician specializing in infectious diseases, vaccines, immunology, and virology. He is also the co-inventor of a rotavirus vaccine.
Dr. Offit is an internationally recognized expert in the fields of virology and immunology, and was a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention. He is a member of the Food and Drug Administration Vaccines and Related Biological Products Advisory Committee, and a founding advisory board member of the Autism Science Foundation and the Foundation for Vaccine Research, a member of the Institute of Medicine and co-editor of the foremost vaccine text, Vaccines.
During an interview with CNN earlier this month, Dr. Offit said this new Covid booster shot is unlikely to benefit healthy young people and said it’s ‘unfair to make them take a risk.’
Dr. Offit: “When you’re asking people to get a vaccine, I think there has to be clear evidence of benefit. And we’re not going to have clinical studies, obviously, before this launches, but you’d like to have at least human data on people getting this vaccine. You see a clear and dramatic increase in neutralizing antibiotics, and then at least you have a correlate of protection against BA4, BA5. Because if you don’t have that, if there’s not clear evidence of benefit, then it’s not fair [to ask people to take a risk]. The benefits should be clear.”
Watch the video below:
FDA advisor and vaccine maker Paul Offit: “A healthy young person is unlikely to benefit from a booster dose… If there’s not clear evidence of benefit, then it’s not fair to ask people to take a risk.” pic.twitter.com/SgBp5WZbMS
— Max Blumenthal (@MaxBlumenthal) September 24, 2022
Earlier this month, a CDC panel voted in favor of approving the latest Covid booster shot that hasn’t even been tested on humans.
The latest Covid booster, bivalent, was supposedly reformulated to ‘protect’ against Omicron subvariants.
Bivalent boosters contain the original Covid-19 strain and the genetic code of the Omicron sub-variants BA.4 and BA.5.
The new COVID boosters were not tested on humans – only on mice.
The updated booster has only been tested on animals, not people. “There’s no clinical trial data specifically for bivalent BA.4, BA.5 boosters in humans yet, but there will be,” said Dr. Fryhofer.
Dr. Offit wrote an OpEd in Wall Street Journal on September 21.
He said preliminary data suggested the new bivalent vaccines were actually worse at warding off COVID infections than the first generation of shots, Daily Mail reported.
The data suggested shot was not as effective as the first batch.
“The Centers for Disease Control and Prevention recommends that everyone over 12 receive a “bivalent” Covid-19 vaccine as a booster dose. But only a select group are likely to benefit, and the evidence to date doesn’t support the view that a bivalent vaccine containing omicron or its subvariants is better than the monovalent vaccine. The CDC risks eroding the public’s trust by overselling the new shot,” he wrote.